Health Catalyst, Inc. reports results for the quarter ended June 30 - Earnings Summary

Health Catalyst

06/08/2026 22:45

Health Catalyst, Inc. HCAT.OQ reported quarterly adjusted earnings of 4 cents​​ per share for the quarter ended June 30, identical to the same quarter last year.  The mean expectation of six analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from 2 cents to 5 cents per share.
Revenue fell 12.7% to $70.49 million from a year ago; analysts expected $69.06 million. 
Health Catalyst, Inc.'s reported EPS for the quarter was a loss of 55 cents​.
The company reported a quarterly loss of $40.54 million.
Health Catalyst, Inc. shares had risen by 20.1% this quarter and held steady so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 7.5% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the software peer group is also "buy" 
Wall Street's median 12-month price target for Health Catalyst, Inc. is $2.25, about 6.2% below its last closing price of $2.39
This summary was machine generated from LSEG data August 6 at 09:45 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.03
0.04
Beat
Mar. 31 2026 
0.02
0.02
Met
Dec. 31 2025 
0.09
0.08
Missed
Sep. 30 2025 
0.06
0.06
Met